Cardiac rescue with enoximone in volume and catecholamine refractory septic shock

Hannelore I G Ringe1, Verena Varnholt, Gerhard Gaedicke

  • 1Paediatric Intensive Care Unit, Charité Children's Hospital, Humboldt University Berlin, Berlin, Germany. hannelore.ringe@charite.de

Insights

Enoximone effectively restored cardiac function in two children with severe meningococcal septic shock (Waterhouse-Friderichsen syndrome) refractory to standard treatments. This phosphodiesterase inhibitor rapidly improved myocardial contractility and blood pressure, leading to complete recovery.

Area of Science:

  • Pediatric Intensive Care Medicine
  • Cardiology
  • Infectious Diseases

Background:

  • Meningococcal disease, particularly Waterhouse-Friderichsen syndrome, can lead to severe endotoxin shock with refractory cardiovascular collapse.
  • Standard treatments including catecholamines and fluid resuscitation are often insufficient in critical cases.

Observation:

  • Two pediatric patients with meningococcal septic shock (Glasgow score 12) presented with profound cardiovascular deterioration despite maximal conventional therapy.
  • Echocardiography revealed severely impaired cardiac function (shortening fraction <10%) and one patient experienced electromechanical uncoupling requiring external cardiac massage.

Findings:

  • Administration of enoximone, a phosphodiesterase III inhibitor, rapidly improved cardiac output and blood pressure in both patients.
  • Enoximone treatment led to a significant increase in shortening fraction to over 30% and allowed for reduction of catecholamine infusions.

Implications:

  • Enoximone is a promising therapeutic option for severe, catecholamine-refractory endotoxin shock in pediatric patients with meningococcal disease.
  • Early consideration of enoximone may improve outcomes in life-threatening cases of Waterhouse-Friderichsen syndrome with myocardial dysfunction.

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Cardiopulmonary Resuscitation I: Adult01:21

Cardiopulmonary Resuscitation I: Adult

Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...